GHK-Cu + KPV Blend

This blend combines two very short peptides that have each been a research topic for decades. Both are only three amino acids long, but they take different routes.

GHK-Cu is glycyl-histidyl-lysine complexed with a copper ion (Cu2+). This copper tripeptide occurs naturally in human plasma and declines with age. It is well studied in dermatology and cosmetics, largely through the work of Loren Pickart, with reference to wound healing, collagen building and skin regeneration.

KPV is lysine-proline-valine, the C-terminal fragment of the hormone alpha-MSH (alpha-melanocyte-stimulating hormone). It is considered the smallest fragment that still carries the anti-inflammatory action of alpha-MSH without its pigmenting effects.

Together this is a regeneration and anti-inflammation blend: GHK-Cu on the building side (matrix, collagen, vessels), KPV on the braking side (inflammatory signalling). The vial holds 60 mg of combined peptide. This information is for research and educational purposes only. No medical recommendations.

The two components act at different points, which is the logic behind the blend.

GHK-Cu acts in the research context as a modulator of tissue remodeling. Preclinical and dermatological work describes it attracting repair cells, driving synthesis of collagen, elastin and glycosaminoglycans, while modulating the activity of matrix metalloproteinases and their inhibitors. The copper ion plays a central role, including in antioxidant effects and angiogenesis. Pickart also describes very broad gene regulation by GHK.

KPV dampens inflammation. In cell models it inhibits the transcription factor NF-kB and MAP kinase signalling at nanomolar levels, leading to lower secretion of pro-inflammatory cytokines. In intestinal cells, uptake runs through the peptide transporter PepT1; in keratinocytes the signal goes via the MC-1 receptor and intracellular calcium.

To stay honest: most of this data comes from cell culture and animal models, often applied topically or orally. For exactly this blend combination as a subcutaneous injection in humans, there are no controlled studies.

Before you start, have everything ready:

• The GHK-Cu + KPV vial with the freeze-dried powder (often bluish from the copper)
• Bacteriostatic water for reconstitution
• U-100 insulin syringes for the injection
• Alcohol swabs for the vial cap and the skin
• A sealable container for used needles

The powder is dissolved with bacteriostatic water. How much water you use determines the concentration and therefore how many units you draw on the insulin syringe.

Use the calculator above for exactly this: choose vial size and water volume.

Copper tripeptides are mildly light-sensitive. Reconstitute gently (no shaking, let the water run down the inside wall) and protect the finished solution from direct light.

The injection is subcutaneous into the fat layer (abdomen sparing the navel, front of the thigh, back of the upper arm).

• Clean the skin with an alcohol swab
• Pinch up a small skin fold
• Insert the needle at a 45 to 90 degree angle
• Inject slowly, wait briefly, withdraw
• Needle into the sharps container

Rotate the site every time. With this blend an injection-site reaction (redness, brief stinging) is more likely than with plain peptides that contain no copper.

The evidence is decent for the two individual building blocks and thin for the blend.

GHK-Cu: Pickart summarizes across two reviews (2008, 2015) that GHK-Cu supports wound healing, collagen building and tissue remodeling in numerous preclinical models, and is associated with improved skin firmness and reduced lines in cosmetic use. A more recent preclinical paper (Yang 2022) showed accelerated wound healing and angiogenesis for a GHK-functionalized scaffold in a mouse model.

KPV: Dalmasso (2008) and Laroui (2010) showed in Gastroenterology that KPV inhibits NF-kB at nanomolar levels and reduces chemically induced colitis in mice, taken up via the PepT1 transporter. Elliott (2004) characterized KPV as the smallest anti-inflammatory alpha-MSH fragment, signalling through the MC-1 receptor in keratinocytes.

Framed honestly: these are solid preclinical and dermatological findings for the individual peptides. For the injectable blend itself, in humans, there are no controlled clinical trials. Anything beyond that is extrapolation.

Systematic safety data for the injectable blend is missing. What is plausible from experience with the individual peptides:

• Injection-site reaction: redness, brief stinging, itching - tends to be more common with copper peptides
• Temporary local skin discoloration or mild swelling
• With excessive or too-frequent copper intake, theoretically copper-overload concerns - a reason to stay low and not dose high long-term
• General peptide risks: uncertainty about purity and correct reconstitution, infection risk with non-sterile handling

When in doubt, stop and do not keep titrating up. Seek medical advice for persistent or pronounced reactions.

The undissolved powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. Keep the reconstituted solution in the fridge (2 to 8 degrees), where it lasts many weeks. Copper tripeptides are light-sensitive - keep the solution as dark as possible, for example in the box or wrapped to block light.